BCAL Diagnostics is a series b startup. 1 investor tracked. Status: possibledead.
BCAL Diagnostics is a company founded in 2010 headquartered in Australia. Its most recent tracked round is Series B. Brouky records 1 investor associated with the company.
BCAL Diagnostics develops non-invasive blood tests for early detection of breast cancer, designed to complement existing imaging technologies such as mammograms.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.